IGF-1-LONG chimeric protein for stroke treatment, nucleic acid, vector, cell, pharmaceutical composition, method of treatment
Sequence listing
<110>  Limited Liability Company Biochemical Agent
<120>  IGF-1-LONG chimer.prot.for stroke treat.,nuc.acid,vect.,cell,pharm.com.,meth.of tr
<150>  2018131831
<151>  2018-09-05
<170>  PatentIn version 3.5


<210>  1
<211>  70
<212>  PRT
<213>  Artificial sequence
<223>  IGF-1
<400>  1

Gly Pro Glu Thr Leu Cys Gly Ala Glu Leu Val Asp Ala Leu Gln Phe 
1               5                   10                  15      
Val Cys Gly Asp Arg Gly Phe Tyr Phe Asn Lys Pro Thr Gly Tyr Gly 
            20                  25                  30          
Ser Ser Ser Arg Arg Ala Pro Gln Thr Gly Met Val Asp Glu Cys Cys 
        35                  40                  45              
Phe Arg Ser Cys Asp Leu Arg Arg Leu Glu Met Tyr Cys Ala Pro Leu 
    50                  55                  60                  
Lys Pro Ala Lys Ser Ala
65                  70 



<210>  2
<211>  71
<212>  PRT
<213>  Artificial sequence
<223>  IGF-1-Met1
<308>  CAA01954.1
<309>  1995-06-15
<400>  2

Met Gly Pro Glu Thr Leu Cys Gly Ala Glu Leu Val Asp Ala Leu Gln 
1               5                   10                  15      
Phe Val Cys Gly Asp Arg Gly Phe Tyr Phe Asn Lys Pro Thr Gly Tyr 
            20                  25                  30          
Gly Ser Ser Ser Arg Arg Ala Pro Gln Thr Gly Met Val Asp Glu Cys 
        35                  40                  45              
Cys Phe Arg Ser Cys Asp Leu Arg Arg Leu Glu Met Tyr Cys Ala Pro 
    50                  55                  60                  
Leu Lys Pro Ala Lys Ser Ala
65                  70     



<210>  3
<211>  42
<212>  PRT
<213>  Artificial sequence
<223>  long domain
<400>  3

Pro Ala Pro Ala Pro Ala Pro Ala Pro Pro Pro Ala Ala Ala Pro Ala 
1               5                   10                  15      
Pro Ala Pro Ala Pro Ala Pro Pro Pro Ala Ala Ala Pro Ala Pro Ala 
            20                  25                  30          
Pro Ala Pro Ala Pro Pro Pro Ala Ala Ala
        35                  40         



<210>  4
<211>  112
<212>  PRT
<213>  Artificial sequence
<223>  IGF-1-long
<400>  4

Gly Pro Glu Thr Leu Cys Gly Ala Glu Leu Val Asp Ala Leu Gln Phe 
1               5                   10                  15      
Val Cys Gly Asp Arg Gly Phe Tyr Phe Asn Lys Pro Thr Gly Tyr Gly 
            20                  25                  30          
Ser Ser Ser Arg Arg Ala Pro Gln Thr Gly Met Val Asp Glu Cys Cys 
        35                  40                  45              
Phe Arg Ser Cys Asp Leu Arg Arg Leu Glu Met Tyr Cys Ala Pro Leu 
    50                  55                  60                  
Lys Pro Ala Lys Ser Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro Pro 
65                  70                  75                  80  
Pro Ala Ala Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro Pro Pro Ala 
                85                  90                  95      
Ala Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro Pro Pro Ala Ala Ala 
            100                 105                 110         



<210>  5
<211>  113
<212>  PRT
<213>  Artificial sequence
<223>  IGF-1-Met1-long
<400>  5

Met Gly Pro Glu Thr Leu Cys Gly Ala Glu Leu Val Asp Ala Leu Gln 
1               5                   10                  15      
Phe Val Cys Gly Asp Arg Gly Phe Tyr Phe Asn Lys Pro Thr Gly Tyr 
            20                  25                  30          
Gly Ser Ser Ser Arg Arg Ala Pro Gln Thr Gly Met Val Asp Glu Cys 
        35                  40                  45              
Cys Phe Arg Ser Cys Asp Leu Arg Arg Leu Glu Met Tyr Cys Ala Pro 
    50                  55                  60                  
Leu Lys Pro Ala Lys Ser Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro 
65                  70                  75                  80  
Pro Pro Ala Ala Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro Pro Pro 
                85                  90                  95      
Ala Ala Ala Pro Ala Pro Ala Pro Ala Pro Ala Pro Pro Pro Ala Ala 
            100                 105                 110         
Ala
   


